Literature DB >> 35020695

Office-based Methadone Prescribing for Opioid Use Disorder: The Canadian Model.

Robert A Kleinman1, Thomas D Brothers, Marlon Danilewitz, Anees Bahji.   

Abstract

In the context of the US overdose crisis, improving access to medications for opioid use disorder is urgently needed. The Canadian model of methadone treatment, whereby clinicians can prescribe methadone for opioid use disorder in office-based settings and methadone can be dispensed through community pharmacies, offers a compelling model for adoption in the US. Office-based settings in which methadone is prescribed often adopt a rapid-access model, allowing walk-in appointments and same-day initiation of methadone. Prescribing authorization requirements have been relaxed over the past 25 years to improve access to methadone. This paper summarizes the model of office-based methadone prescribing in Canada, highlighting the regulatory structures, prescribing practices, and interprofessional collaborations that enable methadone treatment in office-based settings. Potential implementation strategies for adopting office-based prescribing in the US are discussed.
Copyright © 2022 American Society of Addiction Medicine.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35020695      PMCID: PMC9271524          DOI: 10.1097/ADM.0000000000000950

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   4.647


  28 in total

1.  Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014.

Authors:  Qi Guan; Wayne Khuu; Sheryl Spithoff; Tara Kiran; Meldon Kahan; Mina Tadrous; Diana Martins; Pamela Leece; Tara Gomes
Journal:  Drug Alcohol Depend       Date:  2017-07-19       Impact factor: 4.492

2.  Zoning out methadone and rising opioid-related deaths in Ontario: Reforms and municipal government actions.

Authors:  Carol Strike; Miroslav Miskovic
Journal:  Can J Public Health       Date:  2017-06-16

3.  Perceived Barriers and Facilitators to Providing Methadone Maintenance Treatment Among Rural Community Pharmacists in Southwestern Ontario.

Authors:  Joseph Fonseca; Andrew Chang; Feng Chang
Journal:  J Rural Health       Date:  2017-09-05       Impact factor: 4.333

4.  Harm reduction, methadone maintenance treatment and the root causes of health and social inequities: An intersectional lens in the Canadian context.

Authors:  Victoria Smye; Annette J Browne; Colleen Varcoe; Viviane Josewski
Journal:  Harm Reduct J       Date:  2011-06-30

5.  Prescriptions, power and politics: the turbulent history of methadone maintenance in Canada.

Authors:  B Fischer
Journal:  J Public Health Policy       Date:  2000       Impact factor: 2.222

6.  Methadone Medical Maintenance: An Early 21st-Century Perspective.

Authors:  David M Novick; Edwin A Salsitz; Herman Joseph; Mary Jeanne Kreek
Journal:  J Addict Dis       Date:  2015

7.  Zoned Out: "NIMBYism", addiction services and municipal governance in British Columbia.

Authors:  Scott E Bernstein; Darcie Bennett
Journal:  Int J Drug Policy       Date:  2013-05-13

8.  A call for evidence-based medical treatment of opioid dependence in the United States and Canada.

Authors:  Bohdan Nosyk; M Douglas Anglin; Suzanne Brissette; Thomas Kerr; David C Marsh; Bruce R Schackman; Evan Wood; Julio S G Montaner
Journal:  Health Aff (Millwood)       Date:  2013-08       Impact factor: 6.301

9.  Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report.

Authors:  Paul J Joudrey; Gavin Bart; Robert K Brooner; Lawrence Brown; Julie Dickson-Gomez; Adam Gordon; Sarah S Kawasaki; Jane M Liebschutz; Edward Nunes; Dennis McCarty; Robert P Schwartz; José Szapocnik; Madhukar Trivedi; Judith I Tsui; Arthur Williams; Li-Tzy Wu; David A Fiellin
Journal:  Subst Abus       Date:  2021       Impact factor: 3.716

10.  Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review.

Authors:  Dennis McCarty; Christina Bougatsos; Brian Chan; Kim A Hoffman; Kelsey C Priest; Sara Grusing; Roger Chou
Journal:  Am J Psychiatry       Date:  2021-07-28       Impact factor: 19.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.